AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

PURE Bioscience, Inc.

$0.07 +$0.03 (+67.31%)
OTC · 15 Sep 2026 18:42 UTC
Previous Close
$0.07
Day Range
$0.07 - $0.07
Year Range
$0.04$0.11
Market Cap
8.48M
AVG Volume
28.45K
Trailing/Forward PE
-3.31/-
PEG ratio
-0.14
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02M4M6M8M2016201720182019202020212022202320242025
PURE Revenue (USD) by year
PeriodRevenue (USD)
20252.2M
20241.96M
20231.88M
20221.85M
20213.93M
20206.92M
20191.91M
20181.77M
20171.83M
20161.29M
Net Income (USD)
-15M-10M-5M05M2016201720182019202020212022202320242025
PURE Net Income (USD) by year
PeriodNet Income (USD)
2025-2.4M
2024-3.35M
2023-3.96M
2022-3.49M
2021-2.32M
20204K
2019-6.55M
2018-7.44M
2017-6.26M
2016-14.37M
Operating Income (USD)
-8M-6M-4M-2M02M2016201720182019202020212022202320242025
PURE Operating Income (USD) by year
PeriodOperating Income (USD)
2025-2.27M
2024-3.13M
2023-3.94M
2022-3.42M
2021-2.31M
20204K
2019-5.59M
2018-7.04M
2017-6.01M
2016-7.06M
EBITDA (USD)
-8M-6M-4M-2M02M2016201720182019202020212022202320242025
PURE EBITDA (USD) by year
PeriodEBITDA (USD)
2025-100K
2024-3.05M
2023-3.83M
2022-3.27M
2021-2.14M
2020201K
2019-7.27M
2018-6.8M
2017-6.16M
2016-6.79M
Cash Flows (USD)
-6M-4M-2M02M2016201720182019202020212022202320242025
PURE Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-2.02M
2024-2.53M
2023-3.31M
2022-2.5M
2021-1.69M
2020611K
2019-3M
2018-3.92M
2017-4.79M
2016-5.4M
EPS (USD)
-0.3-0.2-0.1-00.12016201720182019202020212022202320242025
PURE EPS (USD) by year
PeriodEPS (USD)
2025-0.02
2024-0.03
2023-0.04
2022-0.04
2021-0.03
20200.01
2019-0.09
2018-0.11
2017-0.1
2016-0.27
Expenses (USD)
01B2B3B4BR&DSG&ACapex2016201720182019202020212022202320242025
PURE Expenses (USD) by year
PeriodExpenses (USD)
20253.58B
20244.28M
20234.63M
20224.51M
20214.91M
20204.08M
20196.78M
20188.09M
20177.3M
20168.31M
Cash & Debt (USD)
02M4M6MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
PURE Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025334K
2024349K
20231.09M
20223.39M
20212.39M
20203.84M
2019398K
2018851K
20171.64M
20165.19M
Debt ratios
-0.6-0.4-0.2-00.20.420182019202020212022202320242025
PURE Debt ratios by year
PeriodDebt ratios
2025-0.48
2024-0.21
20230.01
20220.27
20210.13
20200.19
20190.01
20180.01
Margins
0%20000%40000%60000%2016201720182019202020212022202320242025
PURE Margins by year
PeriodMargins
202559173.48%
202458.69%
202351.73%
202253.97%
202152.84%
202058.13%
201961.86%
201856.99%
201758.49%
201665.79%
Return on Capital
-1500%-1000%-500%0%500%2016201720182019202020212022202320242025
PURE Return on Capital by year
PeriodReturn on Capital
202546.89%
2024116.97%
2023-1456.25%
2022-89.38%
2021-69.58%
20200.08%
2019-550.76%
2018-580.95%
2017-485.5%
2016-286.1%
Shares Outstanding
050M100M150M2016201720182019202020212022202320242025
PURE Shares Outstanding by year
PeriodShares Outstanding
2025111.86M
2024111.86M
2023111.54M
202288.84M
202187.22M
202086.93M
201975.35M
201868.13M
201762.82M
201664.33M
Book Value Per Share (USD)
-0.0500.050.12016201720182019202020212022202320242025
PURE Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-0.05
2024-0.03
20230
20220.04
20210.04
20200.06
20190.02
20180.02
20170.02
20160.08
Total Assets (USD)
02M4M6M8M2016201720182019202020212022202320242025
PURE Total Assets (USD) by year
PeriodTotal Assets (USD)
20251.06M
2024818K
20231.82M
20224.48M
20214.3M
20206.32M
20191.93M
20182.58M
20173.83M
20167.56M
Employee Count
0510152016201720182019202020212022202320242025
PURE Employee Count by year
PeriodEmployee Count
202511
202411
202311
202215
202110
202010
201910
20189
201710
201613
PE Ratio
010000200003000040000med 68.4Nov 20Dec 20Feb 21Mar 21Apr 21Jun 21
PURE PE Ratio by year
PeriodPE Ratio
Jun 2142.68
Jun 2141.88
May 2143.59
May 2146.15
May 2152.56
May 2154.68
Apr 2152.97
Apr 2155.56
Apr 2155.56
Apr 2159.83
Apr 2160.68
Mar 2164.1
Mar 2165.81
Mar 2165.14
Mar 2159.64
Feb 2169.73
Feb 2176.15
Feb 2172.94
Feb 2168.91
Jan 2166.97
Jan 2169.27
Jan 2175.7
Jan 2172.48
Dec 2071.75
Dec 2067.9
Dec 2064.23
Dec 2018516.75
Dec 2023906.6
Nov 2023037.27
Nov 2024993.26
Nov 2028253.26
Nov 2026949.26
Oct 2028253.26
Oct 2031513.25
Oct 2032817.24
Oct 2032165.25
Free Cash Flow Yield
-50%-40%-30%-20%-10%med -25.12%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PURE Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-22.94%
Sep 26-22.94%
Sep 26-24.71%
Aug 26-17.84%
Aug 26-26.77%
Aug 26-20.08%
Aug 26-24.71%
Jul 26-25.09%
Jul 26-20.93%
Jul 26-24.83%
Jul 26-25.63%
Jul 26-28.89%
Jun 26-22.94%
Jun 26-22.94%
Jun 26-24.89%
Jun 26-24.22%
May 26-20.4%
May 26-22.55%
May 26-23.29%
May 26-23.83%
May 26-24.7%
Apr 26-23.87%
Apr 26-27.17%
Apr 26-21.74%
Apr 26-16.32%
Mar 26-18.89%
Mar 26-19.88%
Mar 26-20.07%
Mar 26-24.78%
Feb 26-26.04%
Feb 26-27.76%
Feb 26-30.02%
Feb 26-32.16%
Jan 26-33.87%
Jan 26-33.08%
Jan 26-33.04%
Jan 26-31.56%
Jan 26-40.38%
Dec 25-33.8%
Dec 25-33.94%
Dec 25-36.27%
Dec 25-36.76%
Nov 25-34.12%
Nov 25-37.61%
Nov 25-33.14%
Nov 25-34.05%
Oct 25-25.73%
Oct 25-25.15%
Oct 25-25.31%
Oct 25-24.05%
Oct 25-20.39%
Sep 25-23.18%
Sep 25-21.14%
Sep 25-22.75%
Sep 25-22.45%
Aug 25-21.92%
Aug 25-20.34%
Aug 25-21.42%
Aug 25-25.05%
Aug 25-22.45%
Jul 25-26.14%
Jul 25-22.71%
Jul 25-22.99%
Jul 25-28.5%
Jun 25-17.49%
Jun 25-17.81%
Jun 25-24.29%
Jun 25-18.33%
May 25-20.6%
May 25-24.59%
May 25-31.5%
May 25-32.67%
May 25-34.29%
Apr 25-30.88%
Apr 25-32.49%
Apr 25-33.6%
Apr 25-28.8%
Mar 25-21.88%
Mar 25-25.2%
Mar 25-33.71%
Mar 25-46.38%
Feb 25-38.65%
Feb 25-35.14%
Feb 25-33.18%
Feb 25-33.93%
Jan 25-32.21%
Jan 25-32.46%
Jan 25-27.64%
Jan 25-29.73%
Jan 25-33.13%
Dec 24-37.34%
Dec 24-27.28%
Dec 24-32.32%
Dec 24-32.79%
Nov 24-25.68%
Nov 24-20.93%
Nov 24-14.37%
Nov 24-20.76%
Nov 24-19.85%
Oct 24-23.66%
Price to Sales
0246810med 3.83Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PURE Price to Sales by year
PeriodPrice to Sales
Sep 263.2
Sep 263.2
Sep 262.97
Aug 264.12
Aug 262.75
Aug 263.66
Aug 262.97
Jul 262.93
Jul 263.51
Jul 262.96
Jul 262.87
Jul 262.54
Jun 263.2
Jun 263.2
Jun 263.04
Jun 263.13
May 263.71
May 263.36
May 263.25
May 263.18
May 263.07
Apr 263.18
Apr 262.79
Apr 263.49
Apr 264.64
Mar 264.01
Mar 263.81
Mar 263.73
Mar 263.02
Feb 262.87
Feb 262.7
Feb 262.49
Feb 262.33
Jan 262.21
Jan 262.26
Jan 262.27
Jan 262.37
Jan 261.85
Dec 252.21
Dec 252.21
Dec 252.52
Dec 252.49
Nov 252.68
Nov 252.43
Nov 252.76
Nov 252.69
Oct 253.56
Oct 254.48
Oct 254.45
Oct 254.68
Oct 255.52
Sep 254.86
Sep 255.32
Sep 254.95
Sep 255.01
Aug 255.13
Aug 255.53
Aug 255.25
Aug 254.49
Aug 255.01
Jul 254.31
Jul 254.96
Jul 254.9
Jul 253.95
Jun 256.44
Jun 256.32
Jun 254.99
Jun 256.61
May 255.88
May 254.93
May 253.84
May 253.71
May 253.53
Apr 253.92
Apr 253.73
Apr 253.6
Apr 254.21
Mar 255.54
Mar 254.81
Mar 254.28
Mar 253.11
Feb 253.73
Feb 254.11
Feb 254.35
Feb 254.25
Jan 254.48
Jan 254.45
Jan 255.22
Jan 254.86
Jan 254.36
Dec 243.87
Dec 245.29
Dec 243.99
Dec 243.93
Nov 245.02
Nov 246.16
Nov 248.97
Nov 246.21
Nov 246.5
Oct 245.33
EV/EBITDA
0200400600800med 67Dec 20Feb 21May 21Jan 26Apr 26Jul 26Sep 26
PURE EV/EBITDA by year
PeriodEV/EBITDA
Sep 2671.74
Sep 2671.74
Sep 2668.75
Aug 2683.72
Aug 2665.75
Aug 2677.73
Aug 2668.75
Jul 2668.15
Jul 2675.77
Jul 2668.56
Jul 2667.35
Jul 2663.12
Jun 2671.74
Jun 2671.74
Jun 2665.72
Jun 2666.72
May 2673.7
May 2669.49
May 2668.21
May 2667.33
May 2666
Apr 2667.28
Apr 2662.67
Apr 2670.98
Apr 2684.77
Mar 2677.24
Mar 2674.86
Mar 2688.26
Mar 2677.7
Feb 2675.53
Feb 2672.87
Feb 2669.85
Feb 2667.39
Jan 2665.64
Jan 2666.42
Jan 2666.46
Jan 2668.05
Jan 2660.33
Dec 2565.7
Dec 2565.57
Jun 2133.67
Jun 2132.99
May 2134.44
May 2136.61
May 2142.02
May 2143.82
Apr 2142.37
Apr 2144.56
Apr 2144.56
Apr 2148.17
Apr 2148.9
Mar 2151.79
Mar 2153.23
Mar 2151.28
Mar 2146.69
Feb 2155.1
Feb 2160.46
Feb 2157.78
Feb 2154.42
Jan 2152.81
Jan 2154.72
Jan 2160.08
Jan 2157.4
Dec 2056.79
Dec 2053.57
Dec 2050.51
Dec 20349.39
Dec 20456.65
Nov 20439.35
Nov 20478.28
Nov 20543.15
Nov 20517.2
Oct 20543.15
Oct 20608.03
Oct 20633.98
Oct 20621
Price/Operating Cashflow
050100150200med 47.26Nov 20Jan 21Mar 21May 21Jul 21Aug 21Oct 21
PURE Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Oct 2128.43
Oct 2127.2
Oct 2129.61
Oct 2131.74
Sep 2132.45
Sep 2133.23
Sep 2133.24
Sep 2127.86
Aug 2126.35
Aug 2128.17
Aug 2130.71
Aug 2133.24
Jul 2134.05
Jul 2135.22
Jul 2135.59
Jul 2135.06
Jul 2136.68
Jun 2140.49
Jun 2135.67
Jun 2136.3
Jun 2135.63
May 2137.08
May 2139.26
May 2144.71
May 2146.52
Apr 2145.06
Apr 2147.26
Apr 2147.26
Apr 2150.9
Apr 2151.62
Mar 2154.53
Mar 2155.99
Mar 2177.86
Mar 2171.28
Feb 2183.34
Feb 2191.02
Feb 2187.18
Feb 2182.36
Jan 2180.05
Jan 2182.8
Jan 2190.47
Jan 2186.63
Dec 2085.76
Dec 2081.15
Dec 2076.76
Dec 20110.71
Dec 20142.94
Nov 20137.74
Nov 20149.44
Nov 20168.93
Nov 20161.13
Oct 20168.93
Oct 20188.42
Oct 20196.22
Oct 20192.32
Price to Book
0204060med 7.7Mar 22Jul 22Oct 22Jan 23May 23Aug 23Dec 23
PURE Price to Book by year
PeriodPrice to Book
Dec 2354.13
Dec 2348.39
Nov 2347.98
Nov 2343.88
Nov 2348.35
Nov 2341.01
Oct 239.05
Oct 239.75
Oct 2310.47
Oct 239.76
Sep 239.85
Sep 239.76
Sep 238.96
Sep 239.67
Sep 239.41
Aug 238.25
Aug 239.38
Aug 239.45
Aug 2311.45
Jul 237.36
Jul 238.87
Jul 239.76
Jul 238.87
Jun 237.09
Jun 237.99
Jun 238.66
Jun 236.95
Jun 236.73
May 235.95
May 236.84
May 235.95
May 235.93
Apr 234.85
Apr 235.93
Apr 235.39
Apr 237.17
Mar 238.25
Mar 237.01
Mar 238.67
Mar 234.83
Mar 235.57
Feb 235.38
Feb 235.57
Feb 234.45
Feb 234.48
Jan 234.45
Jan 233.9
Jan 233.71
Jan 233.34
Dec 223.15
Dec 224.57
Dec 225
Dec 223.07
Dec 223.18
Nov 223.18
Nov 223.41
Nov 223.64
Nov 223.98
Oct 224.38
Oct 2211.21
Oct 2210.82
Oct 2210.93
Sep 2211.21
Sep 2212.08
Sep 2212.89
Sep 2212.87
Sep 2212.89
Aug 2211.1
Aug 2211.21
Aug 2212.34
Aug 2211.21
Jul 2211.2
Jul 2212.34
Jul 2211.19
Jul 2210.67
Jul 2211.19
Jun 229.53
Jun 2211.21
Jun 227.99
Jun 228.16
May 227.57
May 227.69
May 227.57
May 227.09
Apr 226.97
Apr 226.72
Apr 227.66
Apr 227.97
Apr 227.95
Mar 227.71
Mar 227.37
Mar 225.79
Mar 226.09
Feb 226.09
Feb 226.41
Feb 226.41
Feb 226.59
Jan 226.89
Jan 226.81
Jan 226.43
PURE Bioscience, Inc.
PURE
Stockpicker

Video analysis: PURE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PURE

PURE Bioscience (OTCMKTS:PURE) Stock Price Crosses Above Two Hundred Day Moving Average   – Time to Sell?

defenseworld.net · 2 Sep 2026

PURE Bioscience (OTCMKTS:PURE) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Shares of PURE Bioscience (OTCMKTS:PURE - Get Free Report) passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $0.07 and traded as high as $0.08. PURE Bioscience shares last traded at $0.08, with a volume of 15,969 shares changing hands. PURE

PURE HomeRiver Deepens Its Commitment to AppFolio to Power the Next Phase of Its Growth

globenewswire.com · 26 Aug 2026

PURE HomeRiver Deepens Its Commitment to AppFolio to Power the Next Phase of Its Growth

The 35-state operator consolidates onto AppFolio as it scales toward a 60,000-unit portfolio The 35-state operator consolidates onto AppFolio as it scales toward a 60,000-unit portfolio

Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital Markets

globenewswire.com · 26 Aug 2026

Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital Markets

VANCOUVER, British Columbia, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) (“Purecore” or the “Company”) is pleased to provide a corporate update highlighting progress since its common shares commenced trading on the Canadian Securities Exchange on May 15, 2026.

Purecore Commences Trading on OTCQB to Expand US Investor Access

globenewswire.com · 18 Aug 2026

Purecore Commences Trading on OTCQB to Expand US Investor Access

VANCOUVER, British Columbia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) ("Purecore" or the "Company") announces that its common shares have commenced trading on the OTCQB Venture Market in the United States under the symbol "PPURF". Highlights Purecore common shares now trade on the OTCQB Venture Market in the United States under the symbol "PPURF".

Caliber Goes Live with PURE Pickleball & Padel Tokenized Real Estate Investment Offering

globenewswire.com · 13 Aug 2026

Caliber Goes Live with PURE Pickleball & Padel Tokenized Real Estate Investment Offering

First completed fund tokenization on the Caliber platform, part of an initial program of approximately $100 million of Managed Assets slated for tokenization First completed fund tokenization on the Caliber platform, part of an initial program of approximately $100 million of Managed Assets slated for tokenization

PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above 200 Day Moving Average   – Should You Sell?

defenseworld.net · 12 Aug 2026

PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above 200 Day Moving Average – Should You Sell?

Shares of PURE Bioscience (OTCMKTS:PURE - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.07 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 275 shares traded. PURE Bioscience Trading Up 7.7% The

Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin

globenewswire.com · 30 Jul 2026

Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin

Vancouver, BC, July 30, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd .   (TSX-V:  SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (“Skyharbour” or the “Company”) is pleased to announce that further to its news release dated July 16th, 2026, the Company has entered into a definitive option agreement (the “Option Agreement”) dated July 29th, 2026, with Purecore Metals Inc. (CSE: PURE) (“Purecore”), whereby Purecore may acquire an option (the “Option”) to earn up to a 100% interest in the Yurchison uranium property located in the Wollaston Domain of Northern Saskatchewan, Canada (the “Property”). The Property consists of 22 claims covering approximately 35,029 hectares of mineral tenure.

Skyharbour Signs Letter of Intent with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin

globenewswire.com · 16 Jul 2026

Skyharbour Signs Letter of Intent with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin

Vancouver, BC, July 16, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd .   (TSX-V:  SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (“Skyharbour” or the “Company”) is pleased to announce that the Company has entered into a non-binding letter of intent (the “LOI”) dated July 15th, 2026, with Purecore Metals Inc. (CSE: PURE) (“Purecore”) to option up to a 100% interest in the Yurchison uranium property located in the Wollaston Domain of Northern Saskatchewan, Canada (the “Property”).  The Property consists of 22 claims covering approximately 35,029 hectares of mineral tenure.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.